National policy for rare diseases: challenges on implementation and Health Technology Assessment in the Brazilian Unified Health System (SUS)

Authors

  • Marcela Simões Gestão de Políticas Públicas pela Universidade de São Paulo (USP). Universidade Federal de São Paulo (UNIFESP). Interfarm.
  • Fernanda Lessa Grupo Interdepartamental de Economia da Saúde – GRIDES/UNIFESP
  • Maria José Fagundes Propaganda, Public dade, Promoção e Informação de Produtos Sujeitos a Vigilância Sanitária (GGPRO/ANVISA) Ad Hoc Expert Group em Marketing de Alimentos e Bebidas não alcoólicas para crianças da Organização Mundial da Saúde (OMS). Interfarma (Associação da Indústria Farmacêutica de Pesquisa) e Gestão Industrial Farmacêutica e de Assuntos Regulatórios do IPOG. 

Keywords:

Health Technology Assessment, rare diseases, health policy, orphan drugs

Abstract

The recent publication of the “National Policy on Comprehensive Care for People with Rare Disesses and the Guidelines for Comprehensive Care for People with Rare Diseases within the National Health System”, published via Ordinance 199/2014, has been demonstrated for all actors involved in the political process scheduling, design, implementation, and actually, monitoring, an important advance toward a health care system will be increasingly egalitarian and for all Brazilians. However, it is possible to discuss some structural issues relating to the implementation of this policy process, especially regarding the incorporation of technology in the NHS, the impact, especially the budget to be generated in the system and access challenges imposed on patients and their caregivers. Thus, the aim of this paper is to explain and discuss the scenario of rare diseases in Brazil - especially after the publication of the National Policy on this topic - and the world from the perspective of Health Technology Assessment , highlighting the process obstacles given the need to incorporate specific treatments for these diseases in the Brazilian Unified Health System.

Downloads

Download data is not yet available.

Published

2014-12-20

How to Cite

Simões, M., Lessa, F., & Fagundes, M. J. (2014). National policy for rare diseases: challenges on implementation and Health Technology Assessment in the Brazilian Unified Health System (SUS). Jornal Brasileiro De Economia Da Saúde, 41–47. Retrieved from https://jbes.com.br/index.php/jbes/article/view/366